Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-07

Clinical Trial Update: Long-term Outcome and Lung Capacity in Survivors of ARDS Due to Influenza A (H1N1) v2009 The RESPIFLU Study

View source ↗

Summary

The RESPIFLU study (NCT01271842) reports long-term outcomes and lung capacity in survivors of acute respiratory distress syndrome due to influenza A (H1N1) 2009…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Influenza, Pneumonia, Viral | Status: COMPLETED